Clinical Trial Update: A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis. [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating infliximab (Remicade) in patients with ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED